Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Safety and immunogenicity against ancestral, Delta and Omicron virus variants following a booster dose of an inactivated whole-virus COVID-19 vaccine (VLA2001): Interim analysis of an open-label extension of the randomized, controlled, phase 3 COV-COMPARE trial
Applications will be accepted during the following application dates: December 1-5, January 5-9, and February 2-6 during the hours of 7: 30 am to 6: 00 pm, Monday through Thursday and 7: 30 am to 3: 00 pm on Fridays.